Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression

Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression

(2022) Ana Paula Jesus‐Nunes et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment

(2022) Hitoshi Sakurai et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

(2022) Yazen Alnefeesi et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Depression in young people

(2022) Anita Thapar et al.   LANCET

Translational medicine of the glutamate AMPA receptor

(2021) Tomoyuki MIYAZAKI et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects

(2021) Mai Hatano et al.   Scientific Reports

Early onset of depression and treatment outcome in patients with major depressive disorder

(2021) David P. Herzog et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression

(2021) Mu-Hong Chen et al.   PHARMACOPSYCHIATRY

[11C]K-2 image with positron emission tomography represents cell surface AMPA receptors

(2021) Tetsu Arisawa et al.   NEUROSCIENCE RESEARCH

Visualization of AMPA receptors in living human brain with positron emission tomography

(2020) Tomoyuki Miyazaki et al.   NATURE MEDICINE

Combining machine learning algorithms for prediction of antidepressant treatment response

(2020) Alexander Kautzky et al.   ACTA PSYCHIATRICA SCANDINAVICA

The role of dissociation in ketamine’s antidepressant effects

(2020) Elizabeth D. Ballard et al.   Nature Communications

Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: Post hoc pooled analyses of randomized placebo-controlled and open-label trials

(2020) Mu-Hong Chen et al.   JOURNAL OF AFFECTIVE DISORDERS

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial

(2019) Jennifer L. Phillips et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ketamine in the Treatment of Depressive Episodes

(2019) Philipp Ritter et al.   PHARMACOPSYCHIATRY

The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review

(2019) David S. Mathai et al.   JOURNAL OF AFFECTIVE DISORDERS

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

(2018) Carola Rong et al.   International Journal of Environmental Research and Public Health

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

(2018) Maurizio Fava et al.   MOLECULAR PSYCHIATRY

A New Prediction Model for Evaluating Treatment-Resistant Depression

(2017) Alexander Kautzky et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism

(2017) Lily R. Aleksandrova et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

(2016) Jaskaran B. Singh et al.   AMERICAN JOURNAL OF PSYCHIATRY

The role of adipokines in the rapid antidepressant effects of ketamine

(2016) R Machado-Vieira et al.   MOLECULAR PSYCHIATRY

Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review

(2016) Vera De Carlo et al.   PSYCHIATRY RESEARCH

The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials

(2016) Philip Negt et al.   Brain and Behavior

The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?

(2015) Florian Freudenberg et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression

(2014) Hui Qiao et al.   BEHAVIOURAL BRAIN RESEARCH

Do the dissociative side effects of ketamine mediate its antidepressant effects?

(2014) David A. Luckenbaugh et al.   JOURNAL OF AFFECTIVE DISORDERS

Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression

(2014) Mark J. Niciu et al.   JOURNAL OF CLINICAL PSYCHIATRY

Hippocampal volume and the rapid antidepressant effect of ketamine

(2014) Chadi G Abdallah et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis

(2013) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

(2013) C. N. Haile et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response

(2013) James W. Murrough et al.   PSYCHOPHARMACOLOGY

Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients

(2012) Gonzalo Laje et al.   BIOLOGICAL PSYCHIATRY

Family history of alcohol dependence and antidepressant response to anN-methyl-D-aspartate antagonist in bipolar depression

(2012) David A Luckenbaugh et al.   BIPOLAR DISORDERS

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects

(2012) Vanja Duric et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder

(2012) Jenifer A. Murphy et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidepressants in elderly: Metaregression of double-blind, randomized clinical trials

(2012) Raffaella Calati et al.   JOURNAL OF AFFECTIVE DISORDERS

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

(2011) Gerald W. Valentine et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

HAM-D17and HAM-D6Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder

(2010) P. Bech et al.   PHARMACOPSYCHIATRY

Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic DepressionThe REVAMP TrialAugmentation With CBASP and BSP for Depression

(2009) James H. Kocsis   ARCHIVES OF GENERAL PSYCHIATRY

Family History of Alcohol Dependence and Initial Antidepressant Response to an N -methyl-D-aspartate Antagonist

(2008) Laura E. Phelps et al.   BIOLOGICAL PSYCHIATRY

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

(2008) Gerard Sanacora et al.   NATURE REVIEWS DRUG DISCOVERY

Treatment Outcomes for Older Depressed Patients With Earlier Versus Late Onset of First Depressive Episode: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report

(2007) F Andrew Kozel et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY